TNM classification and the need for revision of pN3a breast cancer
- 1 July 2017
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 79, 23-30
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic reviewInsights into Imaging, 2015
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet, 2015
- Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer PatientsBreast Care, 2014
- Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II–III breast cancer patients treated with neoadjuvant chemotherapyBreast Cancer Research and Treatment, 2013
- Outcomes of locally advanced breast cancer patients with ≥10 positive axillary lymph nodesMedical Oncology, 2013
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox RegressionAmerican Journal of Epidemiology, 2006
- Rethinking TNM: Breast cancer TNM classification for treatment decision-making and researchThe Breast, 2006
- Axillary Lymph Node Status, But Not Tumor Size, Predicts Locoregional Recurrence and Overall Survival After Mastectomy for Breast CancerAnnals of Surgery, 2003
- Revision of breast cancer staging: The 6th edition of the TNM classificationSeminars in Surgical Oncology, 2003
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958